The Challenge of Change - Managing Excipients Control
Colorcon
| « Previous month | Next month » |
Applied Biosystems (ABI) has developed a sequencing-based tool for gene expression analysis that can detect even minute amounts of previously unknown RNA transcripts.
Oxford Diffraction has launched a new dual wavelength X-ray diffractometer that promises to determine the structure of molecules in even the most challenging of crystal samples.
Hungarian researchers have developed a new bioinformatics tool that can identify and correct abnormal, incorrect and mispredicted protein annotations in public databases.
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
Boehringer Ingelheim has formed a strategic production alliance with Chinese manufacturer Hisoar, significantly expanding its worldwide API network.
Codexis and Arch Pharmalabs’ expanded supply and development deal will see the latter produce APIs used in the manufacture of atorvastatin, principal component of Pfizer’s cholesterol buster Lipitor.
The Tel-Aviv District Court has found in favour of Sun Pharmaceuticals in its long running struggle to acquire Israeli drug and pharmaceutical ingredient maker Taro Pharmaceutical Industries.
A facility operated by fatty acid specialist Equateq on the island of Lewis in Scotland has met with UK good manufacturing practice (GMP) standards for the production of lipid-based APIs for the drug industry.
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.
The FDA says that Sandoz, the generics arm of Swiss drug major Novartis, failed to validate manufacturing processes used to produce metoprolol succinate ER tablets at its plant in Wilson, North Carolina.
Shire and Noven have voluntarily withdrawn batches of the ADHD drug Daytrana for the second time in 12 months due to ongoing problems with the product’s release liner.
Drug delivery specialist Eurand is to begin supplying its extended release formulation of cyclobenzaprine HCl to South Korea’s Daewoong Pharmaceuticals.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from innovatis, Stäubli, GE and Sterilin.
NanoBio is believed to be on the verge of securing funding to continue developing its NanoStat drug delivery platform.
in-PharmaTechnologist.com’s periodic round-up of employment developments in the pharmaceutical manufacturing industry includes news on Abbott, Pfizer, Gilead and Clarcor.
The US Food and Drug Administration (FDA) has ordered the seizure of $74,000 worth of Xiadafil VIP tablets after SEI Pharmaceuticals refused to withdraw them from the market.
Researchers claim to have developed a drug delivery system capable of passing through the mucus barrier, which had previously been impenetrable to therapeutics.
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
Agilent recorded strong third quarter revenue growth for its Bio-Analytical segment, which was tempered by the stagnation of income from its Electronic Measurement division.
US researchers have developed a new technique that has enabled them to determine the structure of membrane proteins without having to first crystallise the samples.
Bruker’s X-ray diffraction (XRD) division, Bruker AXS, has agreed to buy German atomic force microscope (AFM) manufacturer S.I.S. Surface Imaging Systems.
OIMBL’s PharmaSense is a versatile MRI tool that allows drugmakers to assess tablet dynamics and potentially improve API delivery, according to company managing director Frank Trundle.
Evaluating the sugars used to stabilise proteins will be faster, cheaper and more efficient thanks to new technology, claim researchers.
US-based biotech ArmaGen Technologies has received funding from the Michael J Fox Foundation (MJFF) for the development of its drug delivery technology.
People employed in the pharmaceutical industry in New Jersey, USA fell by one per cent in 2007, according to a report by the HealthCare Institute of New Jersey (HINJ).
US researchers have developed a chemoenzymatic strategy to synthesise the anticoagulant drug heparin and avoid the contaminant that has killed more than 80 people.
APP Pharmaceuticals, currently the sole supplier of therapeutic heparin vials to the US market, has received FDA approval to manufacture three new formulations of the blood-thinner at its plant in Barceloneta, Puerto Rico.
Conformia says that the integration of its SOA data platform into IBM’s system will provide drugmakers with robust management architecture for the entire lifecycle of a product.
CRO Rubicon Research and chemicals manufacturer Mallinckrodt Baker are teaming up to develop the PanExcea excipient range, which was launched by the latter firm’s parent company Covidien in July.
The impact counterfeit pharmaceuticals can have on a company’s sales has been highlighted by Tongjitang Chinese Medicines’ (TCM) second quarter results.
The US Pharmacopeia (USP) has continued to expand its global reach by opening a site in São Paulo, Brazil; its first in Latin America.
in-PharmaTechnologist.com's round-up of developments in pharmaceutical manufacturing features news of SAFC’s new highly potent API plant, ISPE’s Facility of the Year Awards and Israel’s proposed entry into PIC/S.
An increase in the sale of vaccines such as Quinvaxem and Epaxal, helped Dutch drugmaker Crucell reduce its loss some 56 per cent to €7.9m ($12.5m) in the second quarter.
Advalytix’ AmpliGrid technology is playing a key role in enabling researchers to discover how just a single cell can lay a huge role in complex biological systems.
Researchers have used Affymetrix Genome-Wide Human SNP (single nucleotide polymorphism) arrays to discover genetic variations that increase the risk of schizophrenia.
Dutch assay experts Qiagen reported a 61 per cent jump in revenues helped by its $1.6bn (€1.07bn) acquisition of Digene towards the end of last year.
Bio-Rad has reported second-quarter revenue growth of 33 per cent due to its acquisition of laboratory diagnostics firm DiaMed and strong organic growth.
in-PharmaTechnologist.com’s latest round up of developments in the field of pharmaceutical packaging includes 3S’ counterfeit solution and new machines for Xcelience and Medica.
US-based DSM Biologics and MorphoSys are teaming up to manufacture the MOR202 antibody, which has shown considerable promise as a treatment for multiple myeloma (MM).
Genentech’s special advisory committee has rejected Roche’s $44bn offer for the biotech believing that it “substantially undervalues” the company.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Millipore, Sensor Products and Aspex.
An insurance policy intended to cover against the pitfalls faced by pharmaceutical manufacturers and distributors has been launched by Lloyds’ underwriter Kiln and broker Jardine Lloyd Thompson (JLT).
Siemens has outlined plans to establish itself as a leading provider of radiopharmaceuticals in India through the construction of numerous manufacturing facilities.
A new report predicts that current global sales leader Pfizer will relinquish its position by 2014 leaving European pharmaceutical producers like Roche and Sanofi-Aventis free to vie for the top spot.
in-PharmaTechnologist’s latest round up of developments in the field of drug delivery includes Cosmo gaining a US patent, Alchemy’s nasal delivery device and the use of plant viruses in nanotechnology.
Researchers claim to have facilitated the development and manufacture of a wide range of alkaloids using genetically modified yeast.
The gulf in rates of growth between emerging and established markets in the biotech active pharmaceutical ingredient (API) sector has been highlighted in a new report from the Chemical Pharmaceutical Generic Association (CPA).
in-PharmaTechnologist.com's round-up of developments in the pharmaceutical manufacturing space features news of TGA approval for Capsugel’s plant, Spain’s first therapeutic protein plant and Isogen setting up in Delaware.
The US Food and Drug Administration (FDA) is seeking feedback from the pharmaceutical industry to develop the recommendations of the Nanotechnology Task Force.
University of York, UK, spin-out Paraytec, has published new results that extend the use of its ActiPix UV area imaging detector to applications in enzyme assays and protein sizing.
Integrated DNA Technologies (IDT) has completed the expansion of its European production facility, enabling the company to supply its European customers faster than ever before.
Bruker recorded a 31 per cent increase in revenue for the second quarter, marking a strong start after it acquired its affiliated Bruker BioSpin in February for $914m.
Veeco Instruments returned to profitability with the company’s ‘best quarterly performance in two years’ even though its metrology unit struggled due to weakness in the semiconductor market.
TTP LabTech has launched the RAPid 4 - a flow-based biosensor that can conduct real-time label-free molecular interaction analysis in buffered solutions and in complex biological mixtures.
Ampac Fine Chemicals has posted disappointing results for the third quarter of its fiscal year, which saw operating income slump from $5m to $0.6m.
in-PharmaTechnologist.com presents its periodic round-up of developments in pharmaceutical packaging, including Comar’s new dosage cup and Arcadia’s system for increasing patient compliance.
US packaging specialist West Pharmaceutical Services has carried the earnings momentum it generated in the first three months of the year through to the second quarter.
Generic drugmaker Actavis Totowa has voluntarily recalled all drugs produced at its Little Falls, New Jersey manufacturing facility after an FDA inspection uncovered several breaches of current GMP codes.
US protein manufacture and development services provider American Peptide Company (APC) says that its parent company, Ito Life Sciences (ILS), is to be acquired by fellow Japanese firm Otsuka Chemical.
Lonza hopes that the new business it has set up in China will help cement its position as a leading provider of services to the country’s pharmaceutical manufacturing sector.
Gerresheimer has formally started the process to sell off its technical plastics business, keeping its promise to exit non-core businesses and focus on more lucrative sectors such as medical and pharmaceutical plastics.
The lacklustre performance of Millipore’s bioprocess division has continued into the second quarter of the year with revenues reaching $229.8m (€147m) up just one per cent on the comparable 2007 quarter.
Harro Hofliger’s adoption of the FMEA-Med software will help the German machining specialist minimize risk during development operations, according to Canadian developer Dyadem.
in-PharmaTechnologist.com's round-up of developments in the fight against counterfeiting, including Movianto’s ‘DNA’ coding, e-pedigree packaging machinery and a new handheld device.
FMC’s division providing chemicals for the pharmaceutical industry has posted solid results for the second quarter of 2008.
Invitrogen’s plans to buy Applied Biosystems (ABI) are on track with US antitrust regulators approving the deal and both firms achieving strong revenue growth.
Bioprocessing specialist Sartorius Stedim Biotech’s (SSB) net profit for the first half of 2008 rose by 3.5 per cent in comparison with last year, although the company continues to face difficulties in North America.
| « Previous month | Next month » |